Universal-Beteiligungs- und Servicegesellschaft’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.5M Buy
219,652
+78
+0% +$6.16K 0.03% 448
2025
Q4
$17.4M Buy
219,574
+22,140
+11% +$1.67M 0.03% 440
2025
Q3
$12.9M Buy
197,434
+47,595
+32% +$2.32M 0.02% 526
2025
Q2
$5.92M Buy
149,839
+5,969
+4% +$195K 0.01% 756
2025
Q1
$4.34M Buy
+143,870
New +$4.71M 0.01% 858

Other funds holding IONS

Universal-Beteiligungs- und Servicegesellschaft's IONS Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Ionis Pharmaceuticals (IONS) stake by 0.04% in Q1 2026, buying an estimated $6.16K and bringing the position to 219,652 shares worth $16.5M. The position accounts for 0.03% of the portfolio, ranked #448.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in IONS in Q1 2025 and has held it in 5 quarters since. The position peaked at $17.4M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 219,652 shares of Ionis Pharmaceuticals worth $16.5M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 78 Ionis Pharmaceuticals shares in Q1 2026, an estimated $6.16K.
  • Ionis Pharmaceuticals made up 0.03% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #448 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Ionis Pharmaceuticals position peaked at $17.4M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.